MSK begins CAR T cell clinical trial for children with relapsed or treatment-resistant ALL

| April 12, 2015 | 0 Comments

Researchers from Memorial Sloan Kettering Cancer Center are pioneering a new groundbreaking clinical trial for children and young adults with relapsed or treatment-resistant acute lymphocytic leukemia (ALL) by using one of the most promising methods of cancer treatment today, chimeric antigen receptor (CAR) T cells.

View article:
MSK begins CAR T cell clinical trial for children with relapsed or treatment-resistant ALL

Tags: , , , , , , , , , , , ,

Category: Recent News

About the Author ()

Leave a Reply